IPREGNOSTIC Clinical Trial (ongoing)

Clinical validation and model robustness

We are currently carrying out a new clinical study with the aim of validating and reinforcing the predictive model in an expanded cohort.
ClinicalTrials.gov: NCT06716242

Objectives

Expansion of the patient cohort

Increase in preeclampsia cases

Assessment of the robustness of the predictive model

Confirmation of clinical performance in a real-world setting

mapa de los hospitales que participaron en el ensayo clínico de ipregnostic

Current status

Study ongoing — in the recruitment phase.
This study has the approval of the Spanish Agency of Medicines and Medical Devices (AEMPS).

Participation in the study

If you are interested in obtaining more information or considering participation:
ipregnostic.study@ipremom.com
The research team will assess eligibility and provide detailed information with no obligation.